Semen Analysis After Proton Therapy for Prostate Cancer

N/ACompletedNCT01072513

University of Florida31 enrolled

Overview

The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.

Study Type

INTERVENTIONAL

Allocation

Masking

NONE

Enrollment

Conditions

Prostate Cancer

Interventions

Semen analysisOTHER

Semen analysis before and after proton radiation therapy.

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI). Exclusion Criteria: * Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo. * History of vasectomy. * Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin. * Current use of Avodart or Proscar.

Locations (1)

University of Florida Proton Therapy Institute

Jacksonville, Florida, United States

Outcomes

Primary Outcomes

Post treatment sperm count

Time frame: 12 months after radiation therapy

Secondary Outcomes

Compare changes in sperm motility, sperm morphology and semen PH.

This is composite measure

Time frame: 12 months after radiation therapy

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.